YAP1 and ovarian carcinoma: In terms of UCA1, the elevated expression was shown to enhance cell migration, invasion and cisplatin resistance of ovarian cancer [20,21], and the lincRNA activates Hippo-Yes-associated protein (YAP) signaling in ovarian cancer [22].